Where Does GLP-1 Fit In
In the 64-week OASIS 4 trial (307 adults), mean weight loss was 13.6% under the treatment-policy analysis and 16.6% among participants who stayed on treatment, versus about 2% on placebo
Singhai A, Yadav V, Jha RK (2017) Effect of L-carnitine supplementation on inflammatory marker of coronary artery disease
| 2023 | Int J Mol Sci, enzyme families involved in gene expression, stress response, and DNA repair, and a cofactor in the redox reactions that produce ATP
At 1 mL twice a week, about 15 weeks
This treatment is often particularly beneficial for adults who: Have a body mass index (BMI) of 30 or higher Have a BMI of 27 or higher and also have at least one weight-related health condition, like high blood pressure, type 2 diabetes, or high cholesterol